Catalent Inc (CTLT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873

Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.

Data as of 2021-06-19 12:20:50 -0400
Market Cap18.501 Billion Shares Outstanding170.342 Million Avg 30-day Volume922.409 Thousand
P/E Ratio37.19501 Dividend Yield EPS2.96
Price/Sales4.92 Debt to Equity2.15 EBITDA868.8 Million
Price to Book Value4.54 Forward PE Enterprise Value20.661 Billion
Total Cash1.063 Billion Current Debt1.139 Billion Gross Profit1.247 Billion
BETA0.98192 52-week High/Low127.68 / 69.52 Next Earnings Date2021-08-30 Price to Cash FLow (P/CF) 233.2109
Data provided by IEX Cloud
View SEC Filings from CTLT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 8 -62.5% 1 (0.06%) 4 (0.23%) -75.0%
Funds Holding: 469 495 -5.25% 110 (6.49%) 117 (6.79%) -5.98%
13F shares: 164.091 Million 166.574 Million -1.49% 33.02 Million 33.44 Million -1.26%
% Ownership 96.3956 19.3978 20.304 -4.46%
New Positions: 54 96 -43.75% 16 22 -27.27%
Increased Positions 193 197 -2.03% 44 52 -15.38%
Closed Positions 65 40 62.5% 21 23 -8.7%
Reduced Positions 170 169 0.59% 41 41 0.0%
Total Calls 386.976 Thousand 243.43 Thousand 58.97% 170.7 Thousand 52.8 Thousand 223.3%
Total Puts 483.085 Thousand 257.746 Thousand 87.43% 158.55 Thousand 169.5 Thousand -6.46%
PUT/CALL Ratio 1.25 1.06 17.92% 0.93 3.21 -71.03%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CTLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTLT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASTELLANO THOMAS P SVP, CHIEF FINANCIAL OFFICER

  • Officer
12,567 2021-06-01 2

HOPSON RICKY VP, CHIEF ACCOUNTING OFFICER

  • Officer
12,893 2021-06-01 2

GRIPPO MICHAEL J SVP, STRATEGY & CORP. DEV.

  • Officer
17,056 2021-05-10 7

BARBER MICHAEL J

  • Director
0 2021-04-28 2

SCHMIDT KAY A SVP, TECHNICAL OPERATIONS

  • Officer
13,866 2021-03-22 8

CHIMINSKI JOHN R CHAIR & CEO

  • Officer
  • Director
596,362 2021-03-18 7

FASMAN STEVEN L SVP & GENERAL COUNSEL

  • Officer
85,591 2021-03-18 7

JOSEPH WETTENY SVP & CHIEF FINANCIAL OFFICER

  • Officer
49,823 2021-02-16 6

WHITLOW RICCI S PRESIDENT, CSS

  • Officer
2,576 2021-01-21 3

FLYNN KAREN PRES. BIOLOGICS & CCO

  • Officer
34,544 2021-01-11 3

GUNTHER SCOTT SVP, QUALITY & REG. AFFAIRS

  • Officer
16,509 2021-01-06 7

GENNADIOS ARISTIPPOS PRESIDENT SOFTGEL & ORAL TECH

  • Officer
51,315 2021-01-04 5

MASELLI ALESSANDRO PRESIDENT & COO

  • Officer
19,618 2021-01-04 4

ARNOLD JONATHAN PRES. ORAL & SPECIALTY DELIV.

  • Officer
38,602 2021-01-04 6

PRAVDA RICARDO SVP & CHIEF HR OFFICER

  • Officer
13,870 2021-01-04 5

ZIPPELIUS PETER

  • Director
6,428 2020-11-23 3

STAHL JACK L

  • Director
30,777 2020-10-29 2

CLASSON ROLF A

  • Director
30,777 2020-10-29 2

LUCIER GREGORY T

  • Director
24,775 2020-10-29 3

CARROLL J MARTIN

  • Director
26,635 2020-10-29 2

MOREL DONALD E JR

  • Director
52,911 2020-10-29 2

BALACHANDRAN MADHAVAN

  • Director
14,897 2020-10-29 2

CRANE ROSEMARY A

  • Director
11,329 2020-10-29 2

GREISCH JOHN J

  • Director
24,329 2020-10-29 2

KREUZBURG CHRISTA

  • Director
8,765 2020-10-29 3

BUZY PETER L PRESIDENT, GENE THERAPY

  • Officer
45,950 2020-04-09 0

LITTLEJOHNS BARRY PRESIDENT, BIOLOGICS & SDD

  • Officer
45,882 2019-08-22 0

HEGWOOD PAUL W JR PRESIDENT, CSS

  • Officer
11,848 2019-08-22 0

MIYAMOTO LANCE SVP, HUMAN RESOURCES

  • Officer
46,799 2019-03-07 0

DOWNIE WILLIAM SVP, GLOBAL SALES & MARKETING

  • Officer
34,926 2019-02-15 0

ROEHRHOFF UWE

  • Director
16,489 2017-11-21 0

DOLAN CHRISTINE SVP - PRODUCT DEVELOPMENT

  • Officer
19,449 2017-08-29 0

QUELLA JAMES

  • Director
20,641 2017-08-24 0

WALSH MATTHEW M EVP & CHIEF FINANCIAL OFFICER

  • Officer
103,703 2017-08-24 0

JOHNSON SHARON SEE REMARKS

  • Officer
30,829 2017-04-25 0

BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C.

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

BLACKSTONE CAPITAL PARTNERS V L P

BMA V L.L.C.

BLACKSTONE HOLDINGS III L.P.

BLACKSTONE HOLDINGS III GP L.P.

BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
No longer subject to file 2016-09-09 0

BOOTH MELVIN D

  • Director
16,665 2016-08-24 0

LEONARD STEPHEN SEE REMARKS

  • Officer
51,741 2016-07-26 0

HOULTON SCOTT SEE REMARKS

  • Officer
0 2015-09-02 0

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

  • 10% Owner
40,030,960 2015-04-14 0

KURT NIELSEN SEE REMARKS

  • Officer
23,676 2015-02-17 0

MCEVOY BRUCE

  • Director
0 2014-07-31 0

CHU CHINH

  • Director
0 2014-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HOPSON RICKY - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-02 10:14:35 -0400 2021-06-01 A 3,432 a 16,325 direct -0.1092 6.533 6.533 6 -0.1092 2

CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

2021-06-02 10:14:51 -0400 2021-06-01 A 2,451 a 15,018 direct -0.1092 6.533 6.533 6 -0.1092 2

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2021-05-24 14:47:01 -0400 2021-05-10 G 10 d 17,056 direct 0.8678 -0.5363 2.4766 4 -0.5363 6

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2021-05-24 14:47:01 -0400 2021-05-10 G 10 d 17,066 direct 0.8678 -0.5363 2.4766 4 -0.5363 6

BARBER MICHAEL J - Director

2021-04-30 20:09:20 -0400 2021-04-28 A 845 a 845 direct -7.4074 -6.2444 -2.9612 0.0 1 -10.2344 12

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CATALENT INC CTLT 2021-06-18 22:15:03 UTC -0.2097 0.2897 7300000
CATALENT INC CTLT 2021-06-18 21:45:03 UTC -0.2118 0.2918 7300000
CATALENT INC CTLT 2021-06-18 21:15:03 UTC -0.2118 0.2918 7300000
CATALENT INC CTLT 2021-06-18 20:45:03 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 20:15:04 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 19:45:03 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 19:15:03 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 18:45:03 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 18:15:02 UTC -0.2112 0.2912 7300000
CATALENT INC CTLT 2021-06-18 17:45:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 17:15:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 16:45:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 16:15:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 15:45:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 15:15:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 14:45:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 14:15:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 13:45:03 UTC -0.247 0.287 7300000
CATALENT INC CTLT 2021-06-18 13:15:03 UTC -0.247 0.287 7200000
CATALENT INC CTLT 2021-06-18 12:45:03 UTC -0.247 0.287 7200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund CTLT -1986.0 shares, $-111811.8 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund CTLT -1742.0 shares, $-98074.6 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund CTLT -7587.0 shares, $-361596.42 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund CTLT -24803.0 shares, $-1182110.98 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund CTLT -68.0 shares, $-3532.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund CTLT -105.0 shares, $-5454.75 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund CTLT -867.0 shares, $-41321.22 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CTLT -127.0 shares, $-6597.65 2020-03-31 N-PORT
PACE SELECT ADVISORS TRUST- PACE Large Co Value Equity Investments CTLT -15716.0 shares, $-1808125.8 2021-01-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND CTLT -1532.0 shares, $-176256.6 2021-01-31 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund CTLT 6377.0 shares, $-725128.67 2021-02-28 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund CTLT -6500.0 shares, $-739115.0 2021-02-28 N-PORT
GMO TRUST- GMO Benchmark-Free Fund CTLT -10800.0 shares, $-1228068.0 2021-02-28 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund CTLT -2400.0 shares, $-272904.0 2021-02-28 N-PORT
GMO TRUST- GMO Implementation Fund CTLT -29800.0 shares, $-3388558.0 2021-02-28 N-PORT
GMO TRUST- GMO Alternative Allocation Fund CTLT -1400.0 shares, $-159194.0 2021-02-28 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CTLT -300.0 shares, $-31593.0 2021-03-31 N-PORT
FundVantage Trust- Gotham Hedged Core Fund CTLT -709.0 shares, $-74664.79 2021-03-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund CTLT -178.0 shares, $-18745.18 2021-03-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund CTLT -37.0 shares, $-3896.47 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund CTLT -412.0 shares, $-43387.72 2021-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund CTLT -660.0 shares, $-69504.6 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund CTLT -1109.0 shares, $-116788.79 2021-03-31 N-PORT

Elevate your investments